Editorial
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 15, 2000; 6(5): 626-629
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.626
Design, delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo
Wolfgang H. Caselmann, Matthias Serwe, Thomas Lehmann, Janos Ludwig, Brian S. Sproat, Joachim W. Engels
Wolfgang H. Caselmann, Matthias Serwe, Department of Medicine I, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany
Thomas Lehmann, Joachim W. Engels, Institute for Organic Chemistry, University of Frankfurt, D-60439 Frankfurt/Main, Germany
Janos Ludwig, Brian S. Sproat, Innovir GmbH, D-37124 Rosdorf, Germany
Author contributions: All authors contributed equally to the work.
Correspondence to: Wolfgang H. Caselmann, Department of Medicine I, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany. Caselmann@Uni-Bonn.de
Telephone: 0049-228/287-5511 Fax: 0049-228/287-4698
Received: August 20, 2000
Revised: August 23, 2000
Accepted: August 25, 2000
Published online: October 15, 2000
Abstract